Best Deal of the Month · Apex Trader Funding 90% OFF — code ONKAGNVZ Claim Now
Friday · May 1, 2026
BULENOX . PAYOUT PROOF

Trader @FarmforAnswers Reports Passing Bulenox Evaluations on X

On Tuesday, January 27, the trader @FarmforAnswers posted on X that he had passed evaluations with Bulenox, listing the firm alongside several other prop accounts in a wider update on his trading week.

Verified Jun 14·by Jean Babwel
January 27, 2026Source · X @FarmforAnswersReading time · 2 min

The Bulenox reference appears in a multi-firm status update rather than a standalone payout receipt. In the post, @FarmforAnswers writes plainly, "Passed some bulenox evals," placing the firm in a list that also includes Tradeify, FN Futures, Take Profit Trader, TradeDay, and Alpha Futures. The note documents evaluation progress with Bulenox on that date, nothing more.

The headline financial figure in the same post is not tied to Bulenox. The trader states he made $25,000 live on a Tradeify account and requested a $7,300 payout there, which he says pushed his cumulative requested total past $100,000 from that account. Those numbers belong to a different firm and should not be read as Bulenox performance.

Screenshot from @FarmforAnswers X post dated January 27 referencing passed Bulenox evaluations.
Source · X @FarmforAnswers · January 27, 2026View original →
Passed some bulenox evals.@FarmforAnswers on X, January 27

What the proof establishes for Bulenox is narrow but specific. As of January 27, the trader publicly claimed to have cleared one or more Bulenox evaluation accounts. The post does not disclose the account size, the instruments traded, the strategy used, or the time taken to pass. It also does not show a Bulenox payout, a Bulenox dashboard screenshot, or a funded-account transition.

For readers tracking Bulenox specifically, the value of this post is limited to evaluation throughput. It is one active multi-firm trader confirming that the Bulenox challenge was passable for him in the same week he was working accounts at several competitors. Anything beyond that, including profit split, payout cadence, or rule treatment at Bulenox, is not addressed in the source and is not assumed here.